Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000039756Phase 4Recruiting
Phase 4, open-label trial of Huatuo Zaizao in ischemic stroke and atherothrombotic stroke (2 arms), sponsored by Xiyuan Hospital. Primary endpoints: NIHSS score, ADL score and 9 more. Started Dec 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000039756.